BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32268790)

  • 1. Endothelial Scaffolding Protein ENH (Enigma Homolog Protein) Promotes PHLPP2 (Pleckstrin Homology Domain and Leucine-Rich Repeat Protein Phosphatase 2)-Mediated Dephosphorylation of AKT1 and eNOS (Endothelial NO Synthase) Promoting Vascular Remodeling.
    Huang J; Cai C; Zheng T; Wu X; Wang D; Zhang K; Xu B; Yan R; Gong H; Zhang J; Shi Y; Xu Z; Zhang X; Zhang X; Shang T; Zhou J; Guo X; Zeng C; Lai EY; Xiao C; Chen J; Wan S; Liu WH; Ke Y; Cheng H
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1705-1721. PubMed ID: 32268790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.
    Symons JD; McMillin SL; Riehle C; Tanner J; Palionyte M; Hillas E; Jones D; Cooksey RC; Birnbaum MJ; McClain DA; Zhang QJ; Gale D; Wilson LJ; Abel ED
    Circ Res; 2009 May; 104(9):1085-94. PubMed ID: 19342603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1.
    Ching LC; Kou YR; Shyue SK; Su KH; Wei J; Cheng LC; Yu YB; Pan CC; Lee TS
    Cardiovasc Res; 2011 Aug; 91(3):492-501. PubMed ID: 21493704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
    Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin.
    d'Uscio LV; Smith LA; Santhanam AV; Richardson D; Nath KA; Katusic ZS
    Hypertension; 2007 May; 49(5):1142-8. PubMed ID: 17372034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gab1, SHP2, and protein kinase A are crucial for the activation of the endothelial NO synthase by fluid shear stress.
    Dixit M; Loot AE; Mohamed A; Fisslthaler B; Boulanger CM; Ceacareanu B; Hassid A; Busse R; Fleming I
    Circ Res; 2005 Dec; 97(12):1236-44. PubMed ID: 16284184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury.
    Wegiel B; Gallo DJ; Raman KG; Karlsson JM; Ozanich B; Chin BY; Tzeng E; Ahmad S; Ahmed A; Baty CJ; Otterbein LE
    Circulation; 2010 Feb; 121(4):537-48. PubMed ID: 20083679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
    Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial nitric oxide synthase gene transfer restores endothelium-dependent relaxations and attenuates lesion formation in carotid arteries in apolipoprotein E-deficient mice.
    Mujynya-Ludunge K; Viswambharan H; Driscoll R; Ming XF; von Segesser LK; Kappenberger L; Yang Z; Vassalli G
    Basic Res Cardiol; 2005 Mar; 100(2):102-11. PubMed ID: 15578196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide.
    Raman KG; Gandley RE; Rohland J; Zenati MS; Tzeng E
    J Vasc Surg; 2011 Mar; 53(3):754-63. PubMed ID: 21163611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway.
    Chavakis E; Dernbach E; Hermann C; Mondorf UF; Zeiher AM; Dimmeler S
    Circulation; 2001 Apr; 103(16):2102-7. PubMed ID: 11319202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional cross-regulation between the endothelial nitric oxide synthase and β-catenin signalling pathways.
    Warboys CM; Chen N; Zhang Q; Shaifta Y; Vanderslott G; Passacquale G; Hu Y; Xu Q; Ward JP; Ferro A
    Cardiovasc Res; 2014 Oct; 104(1):116-26. PubMed ID: 25062958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein.
    Procopio C; Andreozzi F; Laratta E; Cassese A; Beguinot F; Arturi F; Hribal ML; Perticone F; Sesti G
    Endocrinology; 2009 Aug; 150(8):3584-93. PubMed ID: 19359389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of endothelial progenitor cells overexpressing endothelial nitric oxide synthase enhances inhibition of neointimal hyperplasia and restores endothelium-dependent vasodilatation.
    Cui B; Huang L; Fang Y; Guo R; Yin Y; Zhao X
    Microvasc Res; 2011 Jan; 81(1):143-50. PubMed ID: 20888843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells.
    Hung MJ; Cherng WJ; Hung MY; Wu HT; Pang JH
    J Hypertens; 2010 May; 28(5):940-51. PubMed ID: 20375905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction.
    Kawakami A; Osaka M; Tani M; Azuma H; Sacks FM; Shimokado K; Yoshida M
    Circulation; 2008 Aug; 118(7):731-42. PubMed ID: 18663085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits.
    Yang X; Gong Y; He Q; Licht JD; Liaw L; Friesel RE
    J Cell Biochem; 2018 Apr; 119(4):3267-3279. PubMed ID: 29105817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase.
    Hambrecht R; Adams V; Erbs S; Linke A; Kränkel N; Shu Y; Baither Y; Gielen S; Thiele H; Gummert JF; Mohr FW; Schuler G
    Circulation; 2003 Jul; 107(25):3152-8. PubMed ID: 12810615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.